Creation of a fully active, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase by the deletion of a membrane-spanning domain
- PMID: 10514560
- DOI: 10.1677/jme.0.0230231
Creation of a fully active, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase by the deletion of a membrane-spanning domain
Abstract
Human 3beta-hydroxysteroid dehydrogenase/steroid Delta(5)-Delta(4)-isomerase (3beta-HSD/isomerase) is a bifunctional, single enzyme protein that is membrane-bound in the endoplasmic reticulum (microsomes) and mitochondria of cells in the placenta (type I) and in the adrenals and gonads (type II). Two membrane-binding domains (residues 72-89 and 283-310) have been predicted by analyses of hydrophobicity in the type I and II isoenzymes (90% regional homology). These putative membrane domains were deleted in the cDNA by PCR-based mutagenesis, and the two mutant enzymes were expressed by baculovirus in insect Sf9 cells. Differential centrifugation of the Sf9 cell homogenate containing the 283-310 deletion mutant revealed that 94% of the 3beta-HSD and isomerase activities were in the cell cytosol, 6% of the activities were in the microsomes, and no activity was in the mitochondria. This is the opposite of the subcellular distribution of the wild-type enzyme with 94% of the activities in the microsomes and mitochondria and only 6% activity in the cytosol. The organelle distribution of the 72-89 deletion mutant lies between these two extremes with 72% of the enzyme activity in the cytosol and 28% in the microsomes/mitochondria. The integrity of the subcellular organelle preparations was confirmed by electron microscopy. Western immunoblots confirmed the presence of the 283-310 deletion mutant enzyme and the absence of the wild-type enzyme in the insect cell cytosol. The unpurified, cytosolic 383-310 deletion mutant exhibited 3beta-HSD (22 nmol/min per mg) and isomerase (33 nmol/min per mg) specific activities that were comparable with those of the membrane-bound, wild-type enzyme. The isomerase reaction of the cytosolic 283-311 deletion mutant requires activation by NADH just like the isomerase of the microsomal or mitochondrial wild-type enzyme. In contrast, the 72-89 deletion mutant had low 3beta-HSD and isomerase specific activities that were only 12% of the wild-type levels. This innovative study identifies the 283-310 region as the critical membrane domain of 3beta-HSD/isomerase that can be deleted without compromising enzyme function. The shorter 72-89 region is also a membrane domain, but deletion of this NH(2)-terminal region markedly diminishes the enzyme activities. Purification of the active, cytosolic 283-310 deletion mutant will produce a valuable tool for crystallographic studies that may ultimately determine the tertiary/quaternary structure of this key steroidogenic enzyme.
Similar articles
-
The engineered, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase: purification, characterization and crystallization.J Mol Endocrinol. 2001 Aug;27(1):77-83. doi: 10.1677/jme.0.0270077. J Mol Endocrinol. 2001. PMID: 11463578
-
Site-directed mutagenesis identifies amino acid residues associated with the dehydrogenase and isomerase activities of human type I (placental) 3beta-hydroxysteroid dehydrogenase/isomerase.J Steroid Biochem Mol Biol. 1998 Sep;66(5-6):327-34. doi: 10.1016/s0960-0760(98)00058-2. J Steroid Biochem Mol Biol. 1998. PMID: 9749838
-
Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.J Steroid Biochem Mol Biol. 1992 Dec;43(8):805-26. doi: 10.1016/0960-0760(92)90308-6. J Steroid Biochem Mol Biol. 1992. PMID: 22217825
-
Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.Endocr Rev. 2005 Jun;26(4):525-82. doi: 10.1210/er.2002-0050. Epub 2005 Jan 4. Endocr Rev. 2005. PMID: 15632317 Review.
-
Human placental 3β-hydroxysteroid dehydrogenase/steroid Δ5,4-isomerase 1: Identity, regulation and environmental inhibitors.Toxicology. 2019 Sep 1;425:152253. doi: 10.1016/j.tox.2019.152253. Epub 2019 Jul 25. Toxicology. 2019. PMID: 31351905 Review.
Cited by
-
Accelerated molecular evolution of insect orthologues of ERG28/C14orf1: a link with ecdysteroid metabolism?J Genet. 2001 Apr;80(1):17-21. doi: 10.1007/BF02811414. J Genet. 2001. PMID: 11910120
-
Substrate specificity and kinetic mechanism of 3β-hydroxy-Δ5-C27-steroid oxidoreductase.J Biol Chem. 2024 Dec;300(12):107945. doi: 10.1016/j.jbc.2024.107945. Epub 2024 Nov 4. J Biol Chem. 2024. PMID: 39505210 Free PMC article.
-
Theoretical Improvements in Enzyme Efficiency Associated with Noisy Rate Constants and Increased Dissipation.Entropy (Basel). 2024 Feb 9;26(2):151. doi: 10.3390/e26020151. Entropy (Basel). 2024. PMID: 38392406 Free PMC article.
-
Mitochondrial 3 beta-hydroxysteroid dehydrogenase (HSD) is essential for the synthesis of progesterone by corpora lutea: an hypothesis.Reprod Biol Endocrinol. 2005 Apr 3;3:11. doi: 10.1186/1477-7827-3-11. Reprod Biol Endocrinol. 2005. PMID: 15804366 Free PMC article.
-
Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics.J Steroid Biochem Mol Biol. 2007 Oct;107(1-2):88-99. doi: 10.1016/j.jsbmb.2007.03.037. Epub 2007 Jun 8. J Steroid Biochem Mol Biol. 2007. PMID: 17689071 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources